ArticleBoneKEy reports2015

Sclerostin inhibits osteoblast differentiation without affecting BMP2/SMAD1/5 or Wnt3a/β-catenin signaling but through activation of platelet-derived growth factor receptor signaling in vitro.

Cyril Thouverey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.